Shares of tech giant Qualcomm Inc. NASDAQ: QCOM have been stuck in a holding pattern for months, but recent signs point to a shift in momentum. After a largely sideways trend since July, the stock has gained 10% since December.

Take-Two Interactive CEO Strauss Zelnick on Grand Theft Auto VI: We couldn't be more excited — Positive
TTWO CNBC Television — February 10, 2025Take-Two Interactive chairman and CEO Strauss Zelnick joins 'Squawk Box' to discuss the company's quarterly earnings results, state of gaming, gaming release pipeline, regulatory and M&A outlook under the new Trump administration, latest news on Grand Theft Auto VI, impact of AI on gaming, and more.

Walmart Grocery Market Share to Increase with Rising Demand for Digital Shopping and Value-Oriented Options — Neutral
WMT GlobeNewsWire — February 10, 2025The report covers Walmart's US sales trends and e-commerce performance from fiscal years 2019 to 2024, and provides estimates of Walmart's US grocery market share from 2021 to 2024. It analyzes the reasons behind and implications of shifts in consumer perceptions and behaviors, highlighting future market opportunities. The report covers Walmart's US sales trends and e-commerce performance from fiscal years 2019 to 2024, and provides estimates of Walmart's US grocery market share from 2021 to 2024. It analyzes the reasons behind and implications of shifts in consumer perceptions and behaviors, highlighting future market opportunities.

2 Stocks to Shield Your Portfolio from AI and Tech Froth — Neutral
PM XOM MarketBeat — February 10, 2025In the current state of the stock market, investors argue over whether valuations are too high. Some see historical indicators as signs of doom, while others feel that future earnings will justify prices.

TIXT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TELUS International (Cda) Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
TIXT Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TELUS International (Cda) Inc. ("TELUS" or "the Company") (NYSE:TIXT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TELUS securities between February 16, 2023 and August 1, 2024, both dates inclusive (the "Class Period").

TGT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Target Corporation Investors with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
TGT Accesswire — February 10, 2025NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Target Corporation ("Target" or "the Company") (NYSE:TGT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Target securities between August 26, 2022 and November 19, 2024, both dates inclusive (the "Class Period").

NMRA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
NMRA Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ:NMRA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Neumora securities pursuant to the registration statement and prospectus issued in connection with the Company's September 15, 2023 initial public offering ("IPO").

CROX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Crocs, Inc. to Contact the Firm Today! — Neutral
CROX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Crocs, Inc. ("Crocs" or "the Company") (NASDAQ:CROX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Crocs securities between November 3, 2022 and October 28, 2024, both dates inclusive (the "Class Period").

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Midland States Bancorp, Inc. (MSBI) and Encourages Shareholders to Learn More About the Investigation — Neutral
MSBI Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Midland States Bancorp, Inc. ("Midland States Bancorp" or "the Company") (NASDAQ:MSBI). Investors who purchased Midland States Bancorp securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MSBI.

NEM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Newmont Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
NEM Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Newmont Corporation ("Newmont" or "the Company") (NYSE:NEM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Newmont securities between February 22, 2024 and October 23, 2024, both dates inclusive (the "Class Period").

GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Investors with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
GSK Accesswire — February 10, 2025NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK plc ("GSK" or "the Company") (NYSE:GSK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GSK American Depositary Receipts ("ADRs") between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period").

FTAI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that FTAI Aviation Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
FTAI Accesswire — February 10, 2025NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against FTAI Aviation Ltd. ("FTAI Aviation" or "the Company") (NASDAQ:FTAI) and certain of its officers.

Plastic is Here to Stay-SMX Technology Allows Us to Be Responsible About It — Neutral
SMX Accesswire — February 10, 2025MIAMI, FL / ACCESS Newswire / February 10, 2025 / The recent executive order banning paper straws in the United States marks a pivotal shift in sustainability policy. While well-intentioned, the push for alternatives like Paper Pulp and new chemistry for plastics has been proven problematic and with significant commercial challenges -prone to breaking down, leaving a poor user experience, and requiring resources that aren't always greener.

Cisco and Mistral AI Partner to Deliver on Cisco's Mission to Transform the Customer Experience with AI — Neutral
CSCO PRNewsWire — February 10, 2025First Jointly Developed AI Agent Helps Customers Maximize Cisco Investments and Boosts Productivity News Summary: Powerful Partnership: The first of several AI agents being developed by Cisco with Mistral AI as a strategic technology partner, to help drive Cisco's Customer Experience (CX) move towards an Agentic-AI-Led future. AI-Powered Efficiency: The AI Renewals Agent streamlines and enhances the creation process for Cisco's Renewals team by analyzing data from 50 sources to build custom proposals tied to customer outcomes.

FINAL REMINDER SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Cassava Sciences, Inc. Investors to Participate in the Class Action Lawsuit — Neutral
SAVA Accesswire — February 10, 2025NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or "the Company") (NASDAQ:SAVA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cassava securities between February 7, 2024 and November 24, 2024, both dates inclusive (the "Class Period").

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma — Neutral
NTRA Business Wire — February 10, 2025AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing in the Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for colon cancer, rectal cancer, and merkel cell carcinoma (MCC). In its updated guidelines for colon cancer1 and for rectal cancer2, NCCN now includes ctDNA as a high risk factor for recurrence in.

MGPI Stockholders Have Opportunity to Lead MGP Ingredients, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! — Neutral
MGPI Accesswire — February 10, 2025NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired MGP Ingredients securities between May 3, 2023 and October 30, 2024, both dates inclusive (the "Class Period").

Orion Group Holdings Awarded $211.7 Million in New Contracts — Neutral
ORN GlobeNewsWire — February 10, 2025HOUSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”, “Orion”), a leading specialty construction company, today announced new Marine and Concrete awards for a total value of approximately $211.7 million. These projects are expected to begin in 2025 with varying completion dates extending through 2026. These awards further reinforce Orion's position as a leader in specialized Marine and Concrete construction.

Hain Celestial Reports Fiscal Second Quarter 2025 Financial Results — Neutral
HAIN GlobeNewsWire — February 10, 2025Strong Operating Cash Flow and Reduction in Debt; Positioned to Pivot to Growth in Back Half Exploring Strategic Options for Personal Care Category

BioCryst to Report Fourth Quarter 2024 Financial Results on February 24 — Neutral
BCRX GlobeNewsWire — February 10, 2025RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter 2024 financial results on Monday, February 24, 2025.
